ERBB2 is a gene that codes for proteins that stimulate cell growth and division. When a patient has ERBB2 Gene Amplification, excessive cell division occurs, which can lead to the growth of tumors. Twenty-five percent of breast cancers have ERBB2 Gene Amplification, and the disease has also been found in ovarian, stomach, brain, and lung cancers. Tumors with ERBB2 Gene Amplification are generally more advanced, and have been associated with lower survival rates and increased rates of metastasis. Certain forms of chemotherapy and specific anti-ERBB2 therapies are currently the best treatment option.
Erbb2 Gene Amplification Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Erbb2 Gene Amplification below!
For more information on how to use Laverne, please read the How to Guide.
We have 1810 products for the study of Erbb2 Gene Amplification that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.